Jason Bablak
Operationeel Directeur bij Attune Pharmaceuticals, Inc.
Profiel
Jason Bablak is currently the Chief Operating Officer at Attune Pharmaceuticals, Inc. He previously worked as the Director of Regulatory Affairs at Plasma Protein Therapeutics Association from 1997 to 2000, as an Attorney at Popham Haik, Schnobrich & Kaufman Ltd.
from 1993 to 1995, as the Vice President of Public Policy & Legal Affairs at Immune Deficiency Foundation from 2000 to 2003, as the Vice President of Regulatory Affairs at Thar Pharmaceuticals, Inc., as the Vice President of Regulatory Affairs & Product Development at Lev Pharmaceuticals, Inc. from 2003 to 2008, and as the Vice President & General Counsel at Primaryimmune Services, Inc. Mr. Bablak received his undergraduate degree from Allegheny College and his graduate degree from the University of Pittsburgh Law School.
Actieve functies van Jason Bablak
Bedrijven | Functie | Begin |
---|---|---|
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Operationeel Directeur | - |
Eerdere bekende functies van Jason Bablak
Bedrijven | Functie | Einde |
---|---|---|
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Algemeen Adviseur | - |
Immune Deficiency Foundation | Algemeen Adviseur | 01-01-2003 |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Algemeen Adviseur | 01-01-2000 |
Popham Haik, Schnobrich & Kaufman Ltd. | Corporate Officer/Principal | 01-01-1995 |
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Algemeen Adviseur | - |
Opleiding van Jason Bablak
Allegheny College | Undergraduate Degree |
University of Pittsburgh Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Health Technology |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
Popham Haik, Schnobrich & Kaufman Ltd. | |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
Immune Deficiency Foundation | Miscellaneous |
Primaryimmune Services, Inc. |